respons
pandem
institut
clinic
econom
review
icer
announc
extend
timelin
pend
healthcar
provid
insur
life
scienc
compani
patient
advoc
make
signific
contribut
review
process
current
otherwis
engag
health
crisi
chang
note
includ
indefinit
postpon
public
meet
sickl
cell
diseas
cystic
fibrosi
cf
public
comment
period
remain
open
march
cf
draft
evid
report
push
public
revis
report
around
april
public
ulcer
coliti
draft
evid
report
april
deadlin
input
opportun
delay
month
similarli
review
hemophilia
bladder
cancer
digit
app
opioid
use
disord
put
hold
month
howev
supervis
inject
facil
timelin
unchang
extra
two
month
alreadi
alloc
draft
evid
report
releas
obetichol
acid
icer
releas
draft
evid
report
incorpor
initi
input
patient
clinician
stakehold
apprais
compar
valu
effect
obetichol
acid
intercept
pharmaceut
inc
nonalcohol
steatohepat
nash
line
extens
allow
clinician
respond
pandem
public
comment
accept
draft
june
revis
evid
report
discuss
public
meet
one
icer
independ
evid
apprais
committe
provision
schedul
august
draft
interim
pend
input
taken
final
stakehold
regist
meet
submit
formal
comment
request
make
oral
comment
email
hope
expand
timefram
enabl
stakehold
instead
focu
meet
need
patient
commun
nation
emerg
said
statement
timelin
updat
post
icer
websit
